Impacts and Burden of Niemann pick Type-C: a patient and caregiver perspective.
Illness burden
Impacts
NPC
Niemann pick Type-C
Qualitative
Journal
Orphanet journal of rare diseases
ISSN: 1750-1172
Titre abrégé: Orphanet J Rare Dis
Pays: England
ID NLM: 101266602
Informations de publication
Date de publication:
24 11 2021
24 11 2021
Historique:
received:
04
01
2021
accepted:
06
11
2021
entrez:
25
11
2021
pubmed:
26
11
2021
medline:
12
3
2022
Statut:
epublish
Résumé
Niemann-Pick disease type C (NPC) is a debilitating condition that impacts patients' and caregivers' quality of life (QOL) and reduces the patient's life expectancy. Since there is little qualitative research from the perspective of patients and family caregivers, this study explored the impact of NPC on patients' and caregivers' daily lives to understand the burden of disease. A survey of caregivers for patients with NPC and adult patients with NPC (n = 49; patient age: 13 months-65 years) assessed NPC severity, importance of NPC symptoms, and how symptoms impacted patients' and caregivers' activities of daily living (ADLs) and health-related QOL (HRQOL). Follow-up interviews with a subset of survey participants (n = 28) explored the ranking of NPC symptom importance and impact on ADLs and HRQOL. Findings indicated that the most important manifestations of NPC were ambulation, swallowing, speech, fine motor skills, and cognition, which were those that had the most significant impact on ADLs and HRQOL. A wide range of ADLs were affected by NPC, mainly eating/drinking and the ability to perform daily tasks, including self-care, communicating, participating in school or work, and moving indoors as well as outside the home. Along with these impacts, there was an increased risk of experiencing dangerous or life-threatening situations leading to loss of patient independence and additional caregiver burden, often requiring changes in lifestyle such as giving up work. All aspects of patients' and caregivers' HRQOL were affected. Participants reported feelings of social isolation, loss of enjoyment in activities (patients), and feelings of sadness or worry (caregivers). Ambulation, swallowing, speech, fine motor skills, and cognition are important manifestations of NPC. ADLs and HRQOL were impaired in the majority of patients as well as their caregivers. The findings were independent of current age, age of onset of symptoms, and level of NPC disease-related disability; however, the impact increased at higher levels of disease disability. Knowing the impact of NPC on patients and caregivers is important for understanding the lived experience of NPC and for identifying potential areas of support.
Sections du résumé
BACKGROUND
Niemann-Pick disease type C (NPC) is a debilitating condition that impacts patients' and caregivers' quality of life (QOL) and reduces the patient's life expectancy. Since there is little qualitative research from the perspective of patients and family caregivers, this study explored the impact of NPC on patients' and caregivers' daily lives to understand the burden of disease.
RESULTS
A survey of caregivers for patients with NPC and adult patients with NPC (n = 49; patient age: 13 months-65 years) assessed NPC severity, importance of NPC symptoms, and how symptoms impacted patients' and caregivers' activities of daily living (ADLs) and health-related QOL (HRQOL). Follow-up interviews with a subset of survey participants (n = 28) explored the ranking of NPC symptom importance and impact on ADLs and HRQOL. Findings indicated that the most important manifestations of NPC were ambulation, swallowing, speech, fine motor skills, and cognition, which were those that had the most significant impact on ADLs and HRQOL. A wide range of ADLs were affected by NPC, mainly eating/drinking and the ability to perform daily tasks, including self-care, communicating, participating in school or work, and moving indoors as well as outside the home. Along with these impacts, there was an increased risk of experiencing dangerous or life-threatening situations leading to loss of patient independence and additional caregiver burden, often requiring changes in lifestyle such as giving up work. All aspects of patients' and caregivers' HRQOL were affected. Participants reported feelings of social isolation, loss of enjoyment in activities (patients), and feelings of sadness or worry (caregivers).
CONCLUSIONS
Ambulation, swallowing, speech, fine motor skills, and cognition are important manifestations of NPC. ADLs and HRQOL were impaired in the majority of patients as well as their caregivers. The findings were independent of current age, age of onset of symptoms, and level of NPC disease-related disability; however, the impact increased at higher levels of disease disability. Knowing the impact of NPC on patients and caregivers is important for understanding the lived experience of NPC and for identifying potential areas of support.
Identifiants
pubmed: 34819124
doi: 10.1186/s13023-021-02105-8
pii: 10.1186/s13023-021-02105-8
pmc: PMC8611877
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
493Informations de copyright
© 2021. The Author(s).
Références
Mol Genet Metab. 2015 Sep-Oct;116(1-2):75-9
pubmed: 26189084
Mol Genet Metab. 2012 Jul;106(3):330-44
pubmed: 22572546
Orphanet J Rare Dis. 2018 Aug 16;13(1):143
pubmed: 30115089
Lancet Neurol. 2007 Sep;6(9):765-72
pubmed: 17689147
Biochim Biophys Acta Mol Cell Biol Lipids. 2019 Aug;1864(8):1109-1123
pubmed: 31002946
Traffic. 2010 Apr;11(4):419-28
pubmed: 20059748
Orphanet J Rare Dis. 2013 Feb 22;8:35
pubmed: 23433426
Brain. 2007 Jan;130(Pt 1):120-33
pubmed: 17003072
Neurol Clin Pract. 2017 Dec;7(6):499-511
pubmed: 29431164
Science. 2000 Dec 22;290(5500):2298-301
pubmed: 11125141
Int J Pharm. 2020 Jun 30;584:119440
pubmed: 32428546
Nat Rev Dis Primers. 2018 Oct 1;4(1):27
pubmed: 30275469
Orphanet J Rare Dis. 2018 Apr 6;13(1):50
pubmed: 29625568
J Inherit Metab Dis. 2014 Jan;37(1):93-101
pubmed: 23793527
Orphanet J Rare Dis. 2010 Jun 03;5:16
pubmed: 20525256
Int J Neurosci. 2016 Nov;126(11):963-71
pubmed: 26998855
Am J Med Genet B Neuropsychiatr Genet. 2010 Jan 5;153B(1):132-40
pubmed: 19415691
Orphanet J Rare Dis. 2021 Feb 12;16(1):79
pubmed: 33579322